Page 1

PCR Devices Market is Expected to Reach US$ 5.50 Billion By 2022

Market Research Engine has published a new report titled as “PCR Devices Market By Technology Analysis (Quantitative PCR (qPCR), Digital PCR (dPCR)); By Product Analysis (Quantitative PCR (qPCR), Digital PCR (dPCR)); By Application Analysis (Quantitative PCR (qPCR), Digital PCR (dPCR)); By End User Analysis and By Regional Analysis – Global Forecast by 2016 - 2022” PCR systems have made prepared for progression in life sciences investigate and nuclear diagnostics through its most potential components, for instance, incomparable distinguishing proof and estimation of innate materials, for instance, DNA and RNA. Researchers can assess and explore remarkable alleles and point changes using advanced PCR frameworks, for instance, progressed PCR. Makers are possessed with making PCR framework with redesigned capacities, for instance, wide menu of tests, higher affectability and specificity. Other genuine advances related with the PCR fuse shorter turnaround times (PCR cycling time), higher benefit and robotized work process; as needs be ensuring capable area and increase of inherited materials with exact results. The Global PCR Devices Market is expected to exceed more than US$ 5.31 Billion by 2022 at a CAGR of 8.9% in the given forecast period. You Can Browse Full Report @: https://www.marketresearchengine.com/pcr-devices-market The major driving factors of Global PCR Devices Market are as follows:     

Innovative technological advancements in PCR technology Genetic Disorders and Infectious Diseases are growing In developing economies market penetration is growing Growing public and private investments For Disease Diagnostics use of biomarker profiling is raising

The restraining factors of Global PCR Devices Market are as follows:    

Technical limitations Cost of associated devices is high Unskilled labor and improper data analytical tools New technologies increases competition


The Global PCR Devices Market is segmented on the lines of its technology, treatment, application and regional. Based on technology segmentation it covers Quantitative PCR (qPCR) and Digital PCR (dPCR). On product segmentation it covers Quantitative PCR (qPCR) it includes Instruments, Reagents and Consumables, Software and Services where as in Digital PCR (dPCR) Includes Instruments, Reagents and Consumables, Software and Services. On application basis it covers Quantitative PCR (qPCR), it includes Clinical applications, Research application and Forensic application in Digital PCR (dPCR) includes Clinical applications, Research application and Forensic application. On the segmentation of end users it covers Quantitative PCR (qPCR) which includes Research Laboratories and Academic Institutes, Pharma and Biotech Companies, Hospitals and Diagnostic Centers, Clinical Research Organizations and Forensic Laboratories where as Digital PCR (dPCR) includes Academic Institutes, Pharma and Biotech Companies, Hospitals and Diagnostic Centers, Clinical Research Organizations and Forensic Laboratories. The Global PCR Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries. This report provides: 1)An overview of the global market for PCR Devices Market and related technologies. 2)Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022. 3)Identifications of new market opportunities and targeted promotional plans for PCR Devices Market. 4)Discussion of research and development, and the demand for new products and new applications. 5) Comprehensive company profiles of major players in the industry. Report scope: The scope of the report includes a detailed study of global and regional markets on PCR Devices Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include PCR (qPCR) market include Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), Takara Bio Inc. (Japan),Thermo Fisher Scientific Inc. (U.S.), bioMĂŠrieux S.A. (France), Fluidigm Corporation


(U.S.), Abbot Laboratories (U.S.), and Agilent Technologies, Inc. (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Global PCR Devices Market has been segmented as below: By Technology Analysis:  

Quantitative PCR (qPCR) Digital PCR (dPCR)

By Product Analysis: 

Quantitative PCR (qPCR) o Instruments o Reagents and Consumables o Software and Services Digital PCR (dPCR) o Instruments o Reagents and Consumables o Software and Services

By Application Analysis 

Quantitative PCR (qPCR) o Clinical Applications  Pathogen Testing  Oncology Testing  Blood Screening  Other Clinical Applications o Research Applications o Forensic Applications Digital PCR (dPCR) o Clinical Applications  Pathogen Testing  Oncology Testing  Blood Screening  Other Clinical Applications o Research Applications o Forensic Applications

By End User Analysis: 

Quantitative PCR (qPCR) o Research Laboratories and Academic Institutes


Pharma and Biotech Companies Hospitals and Diagnostic Centers Clinical Research Organizations Forensic Laboratories Digital PCR (dPCR) o Research Laboratories and Academic Institutes o Pharma and Biotech Companies o Hospitals and Diagnostic Centers o Clinical Research Organizations o Forensic Laboratories o o o o

By Regional Analysis:    

North America Europe Asia-Pacific Rest of the World

You Can Browse Full Report @: https://www.marketresearchengine.com/pcr-devices-marke t Table of Contents 1 INTRODUCTION 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global qPCR and dPCR Market, By Technology 8Global qPCR and dPCR Market, By Product and Service 9 qPCR and dPCR Market, By Application 10 qPCR and dPCR Market, By End User 11 qPCR and dPCR Market, By Region


12 Competitive Landscape 13 Company Profiles (Overview, Products and Services, Financials, Strategy & Development)* 1.

Introduction

2.

F. Hoffman-La Roche Ltd.

3.

Thermo Fisher Scientific, Inc.

4.

Bio-Rad Laboratories, Inc.

5.

Qiagen N.V.

6.

Takara Bio, Inc.

7.

Agilent Technologies, Inc.

8.

BiomĂŠrieux S.A.

9.

Fluidigm Corporation

10.

Danaher Corporation

11.

ABBott Laboratories

12.

Merck KGaA

13.

Becton Dickinson and Company

14.

Promega Corporation

15.

Meridian Bioscience, Inc. (Bioline Reagents Ltd.)

16.

Analytik Jena AG (Endress+Hauser Ag)

Media Contact Contact Person: John Bay


Email: john@marketresearchengine.com Phone: +1-855-984-1862 Country: United States Website: https://www.marketresearchengine.com

PCR Devices Market is Expected to Reach US$ 5.50 Billion By 2022  

The Global PCR Devices Market is expected to exceed more than US$ 5.31 Billion by 2022 at a CAGR of 8.9% in the given forecast period.

PCR Devices Market is Expected to Reach US$ 5.50 Billion By 2022  

The Global PCR Devices Market is expected to exceed more than US$ 5.31 Billion by 2022 at a CAGR of 8.9% in the given forecast period.

Advertisement